Analysis · 日本語

製薬分野における価格感度の予測分析 | Predictive Price Sensitivity Analysis: Pharma (JP)

様々な臨床ケースにおいて自己負担額が異なる場合、実在する患者はどのように反応するかを900人以上のクローンで予測した価格感度分析。

Brox.AI· Published ·Also in Türkçe, English
Who was asked
US patient clones, 900 clones
When
February 2026
How
Predicted responses from Brox clones, each built from a long-form interview with a real person, run on the Brox platform.
The full report 製薬分野における価格感度の予測分析 | Predictive Price Sensitivity Analysis: Pharma (JP) Open the report

Section 01: What the study found

  1. #

    7pp

    point drop in willingness for a severe disease despite a 25x copay increase ($10 to $250)

    base 900

  2. #

    37pp

    point drop for a progressive but asymptomatic disease over the same copay range

    base 900

  3. #

    5%

    willingness once prior treatment failures compound with cost, from 30%

    base 900

Section 02: Where this sits

Ask this of your own customers: humans@brox.ai

More in Pharma & HCP

All in Pharma & HCP